ReP USP - Resultado da busca

Trabalho de evento-resumo
Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus (2009)
Hirata, Mario Hiroyuki ; Himelfarb, Silvia Tchernin; Marques, Milano Felipe dos Santos Ferreira; Silva, F. A.; Rodrigues, Alice Cristina ; Sampaio, M. P.; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Silva, Valéria Ferreira da; Rezende, Adriana Augusto de; Monaco, Maria Isabel del; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry. Nome do evento: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Assuntos: DIABETES MELLITUS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. 2009, Anais.. Chicago: American Association for Clinical Chemistry, 2009. p. A223 res. E-41. . Acesso em: 20 jul. 2024.
APA
Hirata, M. H., Himelfarb, S. T., Marques, M. F. dos S. F., Silva, F. A., Rodrigues, A. C., Sampaio, M. P., et al. (2009). Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. In Clinical Chemistry (Vol. 55, p. A223 res. E-41). Chicago: American Association for Clinical Chemistry.
NLM
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 jul. 20 ]
Vancouver
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 jul. 20 ]
Trabalho de evento-resumo periodico
Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone (2009)
Hirata, Mario Hiroyuki ; Marques, Milano Felipe dos Santos Ferreira; Himelfarb, Silvia Tchernin; Silva, F. A.; Monaco, Maria Isabel del; Sampaio, M. P.; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Silva, Valéria Ferreira da; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry. Nome do evento: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Assuntos: DIABETES MELLITUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 20 jul. 2024. , 2009
APA
Hirata, M. H., Marques, M. F. dos S. F., Himelfarb, S. T., Silva, F. A., Monaco, M. I. del, Sampaio, M. P., et al. (2009). Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry.
NLM
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2024 jul. 20 ]
Vancouver
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2024 jul. 20 ]
Trabalho de evento-resumo periodico
Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus (2008)
Hirata, Mario Hiroyuki ; Marques, Milano Felipe dos Santos Ferreira; Himelfarb, Silvia Tchernin; Rodrigues, Alice Cristina ; Silva, F. A.; Silva, Valéria Ferreira da; Monaco, Maria Isabel del; Sampaio, Marcelo Ferraz; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry. Nome do evento: AACC Annual Meeting. Unidade: FCF
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 20 jul. 2024. , 2008
APA
Hirata, M. H., Marques, M. F. dos S. F., Himelfarb, S. T., Rodrigues, A. C., Silva, F. A., Silva, V. F. da, et al. (2008). Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH, Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Monaco MI del, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Hirata RDC. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-69.[citado 2024 jul. 20 ]
Vancouver
Hirata MH, Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Monaco MI del, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Hirata RDC. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-69.[citado 2024 jul. 20 ]
Trabalho de evento-resumo periodico
Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus (2008)
Hirata, Mario Hiroyuki ; Himelfarb, Silvia Tchernin; Marques, Milano Felipe dos Santos Ferreira; Monaco, Maria Isabel del; Rodrigues, Alice Cristina ; Sampaio, Marcelo Ferraz; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Silva, Valéria Ferreira da; Rezende, Adriana Augusto de; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry. Nome do evento: AACC Annual Meeting. Unidade: FCF
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 20 jul. 2024. , 2008
APA
Hirata, M. H., Himelfarb, S. T., Marques, M. F. dos S. F., Monaco, M. I. del, Rodrigues, A. C., Sampaio, M. F., et al. (2008). Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH, Himelfarb ST, Marques MF dos SF, Monaco MI del, Rodrigues AC, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Hirata RDC. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-67.[citado 2024 jul. 20 ]
Vancouver
Hirata MH, Himelfarb ST, Marques MF dos SF, Monaco MI del, Rodrigues AC, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Hirata RDC. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-67.[citado 2024 jul. 20 ]

Unidades USP

ReP

Filtros

Autores

Assuntos